Fundraising FoxMBX Capital
also invests · investor profile2 known investors
Find your way into MBX Capital
Sign up to see every warm intro you have to MBX Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MBX Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MBX Capital is an investment firm that backs companies in the "Deep Health" space, with a portfolio spanning biotech, therapeutics, diagnostics, and life sciences tooling.
Also known as MBX Capital · MBX Capital, LLC
Investors · 2
Company profile
researched Aug 2026MBX Capital, LLC is a venture capital firm focused on early-stage life sciences investing, describing its mandate as backing companies in "Deep Health." Its disclosed portfolio spans therapeutics, diagnostics, medical devices, digital health and life sciences tooling, and includes AmacaThera, Ancilia Bio, Arine, Atlas Health, Attivare Therapeutics, Case45, Catena Biosciences, CND Life Sciences, Contraline, Current Surgical, Dognosis, Earli, Eden, Enoda Cellworks, Examol, Federated Biologics, Freedom Biosciences, Junction Health, Juniper Genomics, Lucy Goods, Macro Trials, Opentrons, Persist AI, Stasis, Think Bioscience, Tidal Vision, Vital Bio, Vivodyne and Waypoint Bio, with additional holdings not individually listed.
The firm identifies Gurdane Bhutani and Zeshan Muhammedi in association with its team, and lists team@mbxcapital.com as its point of contact.
Business model
MBX Capital operates as a venture capital investor, deploying capital into early-stage life sciences companies.
Traction
The firm lists more than 25 named portfolio companies, including AmacaThera, Arine, Contraline, Earli, Opentrons, Tidal Vision, Vital Bio and Vivodyne, and notes additional investments beyond those named.
▸Full profile — market position, go-to-market
Market position
MBX Capital positions itself as an early-stage life sciences venture capital firm centered on a "Deep Health" investment thesis.
Go-to-market
Founders and early-stage companies across therapeutics, diagnostics, medical devices, digital health and life sciences tooling.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
▸Research sources · 1
primary sources listed
- Mbxcapitalmbxcapital.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does MBX Capital do?
- MBX Capital is an early-stage life sciences venture capital firm investing in "Deep Health" companies.
- Who are MBX Capital's investors?
- MBX Capital's investors include Adapt Nation Capital, Evolution VC Partners.